
    
      The investigators examined the frequency of anti-PF4/heparin antibodies (IgG/M/A; EIA) and
      their functional activity (HIPA) in 38 whole organ deceased donor liver transplant
      recipients. Additionally, demographic, clinical, donor- and recipient-specific parameters and
      laboratory findings (ALAT, ASAT, cholinesterase) were investigated.
    
  